Gout and the risk of Parkinson's disease in Denmark

European Journal of Epidemiology

Volumn 28, Issue 4, 2013, Pages 359-360

  Schernhammer, Eva ^a,b,c,g   Qiu, Jiaheng ^d   Wermuth, Lene ^e   Lassen, Christina Funch ^f   Friis, Soren ^f   Ritz, Beate ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c LBI ACR   (Austria)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^g CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZBROMARONE; COLCHICINE; URIC ACID;

CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; FEMALE; GOUT; HUMAN; HYPERURICEMIA; LETTER; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OXIDATIVE STRESS; PARKINSON DISEASE; RISK ASSESSMENT; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DENMARK; DRUG PRESCRIPTIONS; FEMALE; GOUT; GOUT SUPPRESSANTS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PARKINSON DISEASE; POPULATION SURVEILLANCE; REGISTRIES; RISK FACTORS; URIC ACID;

EID: 84878011531     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-013-9791-1     Document Type: Letter

References (15)

1. Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem. 2010;345(1-2):91-104.
2. Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece. Eur J Epidemiol 2013. doi: 10.1007/s10654-012- 9760-0.
3. Church WH, Ward VL. Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation. Brain Res Bull. 1994;33(4):419-25.
4. Tohgi H, Abe T, Takahashi S, Kikuchi T. The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease. J Neural Transm Park Dis Dement Sect. 1993;6(2):119-26.
5. Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM. Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am J Epidemiol. 1996;144(5):480-4.
6. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol. 2005;58(5):797-800.
7. Weisskopf MG, O'Reilly E, Chen H, Schwarzschild MA, Ascherio A. Plasma urate and risk of Parkinson's disease. Am J Epidemiol. 2007;166(5):561-7.
8. Larumbe Ilundain R, Ferrer Valls JV, Vines Rueda JJ, Guerrero D, Fraile P. Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson's disease. Rev Esp Salud Publica. 2001;75(1):43-53.
9. Annanmaki T, Muuronen A, Murros K. Low plasma uric acid level in Parkinson's disease. Mov Disord. 2007;22(8):1133-7.
10. Cipriani S, Chen X, Schwarzschild MA. Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis. Biomark Med. 2010;4(5):701-12.
11. Alonso A, Rodriguez LA, Logroscino G, Hernan MA. Gout and risk of Parkinson disease: a prospective study. Neurology. 2007;69(17):1696-700.
12. De Vera M, Rahman MM, Rankin J, Kopec J, Gao X, Choi H. Gout and the risk of Parkinson's disease: a cohort study. Arthritis Rheum. 2008;59(11):1549-54.
13. Lynge E, Sandegaard JL, Rebolj M. The danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30-3.
14. Pedersen CB. The danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22-5.
15. Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B. Diabetes and the risk of developing Parkinson's disease in Denmark. Diabetes Care. 2011;34(5):1102-8.